Vitrification vs Slow Freezing: The Decision That Changed UK Fertility Treatment
There is a before and after in IVF cryopreservation, and the dividing line is vitrification.
For most of the 1980s and 1990s, embryos were frozen slowly. A programmable machine dropped the temperature incrementally over several hours, carefully timed to work with the cryoprotectant solutions surrounding the embryo. It was a genuine achievement of reproductive science for its time. Survival rates were reasonable. Babies were born. The technique worked.
But slow freezing had a fundamental limitation. At certain temperature ranges during the cooling process, ice crystal formation is almost impossible to prevent entirely. These crystals, even very small ones, cause cellular damage. The damage is not always catastrophic but it is real, and it accumulates.
Vitrification solves this by removing the problematic temperature range from the equation entirely. The embryo, loaded onto a carrier with a small volume of highly concentrated cryoprotectant, is plunged directly into liquid nitrogen at minus 196 degrees Celsius. The speed of cooling, often exceeding 20,000 degrees Celsius per minute, is so fast that the cellular fluid vitrifies rather than crystallising. No ice forms. No crystals. No mechanical damage.
The difference in survival rates is significant and clinically meaningful. Slow-frozen embryos typically survived at 70 to 80 percent. Vitrified embryos in well-run UK laboratories survive at 90 to 95 percent or higher. That is not a minor improvement. For patients who have only a small number of embryos stored, it is the difference between having viable options and not.
The equipment required for vitrification is relatively accessible. A vitrification workstation maintains the working temperature, carrier devices hold the embryo during the plunging process, and the embryo is transferred immediately to long-term storage in a liquid nitrogen dewar.
Closed vitrification systems, where the carrier is sealed to prevent direct contact between the embryo and liquid nitrogen, have gained regulatory preference in some countries for infection control reasons. Open systems remain widely used in UK practice and are considered safe under current HFEA guidance, though the debate continues in the academic literature.
For clinics evaluating equipment or protocols, cryolab.co.uk supplies vitrification workstations, carrier systems, and storage dewars for UK IVF laboratories.
